Researchers in Canada are preparing to launch a new clinical trial that will study the effects of edible cannabis products in the treatment of epilepsy, according to a report from the Canadian Press.
The study will be conducted at Toronto’s Hospital for Sick Children, where researchers intend to get into a first-of-its-kind exploration of oral cannabis concoctions containing both CBD and THC compounds. The goal of this effort is to corroborate some of the anecdotal reports that have surfaced over the past few years that suggest these two primary components of the cannabis plant may have the ability to prevent seizures.
In the United States, similar research has been conducted, but only with respect to CBD or cannabidiol, which is the non-intoxicating aspect of the cannabis plant.
Researchers at the children’s hospital plan to take things a step further by looking into the anticonvulsant properties of both compounds. This move is a